Tesofensine / NS2330

Tesofensine is a triple monoamine reuptake inhibitor that was studied as a potential medication for neurodegenerative disorders; though it did not significantly help these conditions, a weight loss effect was seen sparking further research into using this drug as an anti-obesity drug even though increase in heart rate

Tesofensine is a novel weight loss medication that acts on neurotransmitters in the brain to suppress appetite and increase metabolism. It enhances the levels of norepinephrine, dopamine, and serotonin, crucial neurotransmitters responsible for regulating hunger, satiety, and mood

Tesofensine is a Serotonin-norepinephrine-dopamine-reuptake-inhibitor (SNDRI). SNDRIs are a class of psychoactive antidepressants. They act upon neurotransmitters in the brain, namely, serotonin, norepinephrine and dopamine